AdjuderaGet started

Awarded

1ª prorroga SUMINISTRO DE RANIBIZUMAB 10MG/ML SOLUCIÓN INYECTABLE CON DESTINO AL SERVICIO DE FARMACIA DEL HOSPITAL CLÍNICO SAN CARLOS DE MADRID

Original language: Spanish

Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
Buyer
HOSPITAL CLINICO SAN CARLOS
Winners
LABORATORIO STADA SL, NOVARTIS FARMACEUTICA, S.A., TEVA PHARMA, S.L
Contract value
€2,682,848
Published
2 Sept 2025
Awarded
27 Jun 2025
Contract start
27 Jun 2025
Contract end
15 Jul 2026estimated
Sector
Medical equipment and pharmaceuticals
Region
Madrid
Source
Original notice on TED (573063-2025)

More awards from this buyer

AwardedBuyerWinnerContract valuePublished
ATOGEPANT (AQUIPTA 60 mg comprimidos 28 comprimidos)HOSPITAL CLINICO SAN CARLOSABBVIE SPAIN, S.L€243,58828 Oct 2026
ATOGEPANT (AQUIPTA 10 mg comprimidos 28 comprimidos)HOSPITAL CLINICO SAN CARLOSABBVIE SPAIN, S.L€12,99128 Oct 2026
FILSPARI 400 MG COMPRIMIDOS 30 comprimidosHOSPITAL CLINICO SAN CARLOSVIFOR PHARMA ESPAÑA S.L.€253,39428 Oct 2026
FILSPARI 200 MG COMPRIMIDOS 30 comprimidosHOSPITAL CLINICO SAN CARLOSVIFOR PHARMA ESPAÑA S.L.€9,70428 Oct 2026
2ª prorroga RINGER LACTADO SOLUCIÓN ESTÉRIL Y APRIRÓGENA EN AGUA PARA INYECCIÓN FRASCO PLÁSTICO SEMIRRÍGIDO O BOLSA PLASTICOHOSPITAL CLINICO SAN CARLOSFRESENIUS KABI ESPAÑA, S.A.€17,39023 Oct 2026
2ª prorroga GLUCOSALINO SOLUCIÓN ESTÉRIL Y APRIRÓGENA EN AGUA PARA INYECCIÓN ADMINISTRACIÓN IV FRASCO PLÁSTICO SEMIRRÍGIDO O BOLSA PLASTICOHOSPITAL CLINICO SAN CARLOSFRESENIUS KABI ESPAÑA, S.A.€4,88023 Oct 2026